[cancerpage is a service of Alere]
 


[home]
[search the site]
[my cancerpage]
[ribbon project]
[stories and experiences]
[glossary of terms]
[journal of hope]
[comments]
[about us]
[policies and disclaimers]
[physician and service directories]

High Testosterone Levels Linked To Endometrial Cancer

NEW YORK, Jun 27 (Reuters Health) - High levels of testosterone in the womb could be linked to the development of cancer in the endometrium--the lining of the uterus, according to study results reported at a meeting in Italy this week.

The findings could lead to new treatments for the disease, which is the most common cancer of the female reproductive organs in the US.

Dr. Helen Mertens of the Academic Hospital in Maastricht, the Netherlands, presented her group"s findings to a gathering of the European Society of Human Reproduction and Embryology in Bologna. She said the findings, based on more than 100 postmenopausal women, suggest that testosterone is "at least a co-factor in the development of endometrial cancer."

In a telephone interview with Reuters Health, Mertens said her team measured the levels of hormones in blood from the pelvic area and from other areas of the body. They also looked at the levels of receptors for hormones including estrogen, progesterone and testosterone in the lining of the womb. All of the women in the study had undergone hysterectomy and removal of the ovaries either for endometrial cancer or for other gynecological conditions.

According to Mertens, testosterone was the only hormone that was "significantly higher" in patients with endometrial cancer. "We found no significant differences in pelvic hormone levels for any of the other hormones or for any of the (other areas)," she said in a statement. "Local testosterone levels were higher in patients with endometrial cancer," she further explained to Reuters Health.

Testosterone is one of a group of hormones known as androgens. "These new findings of high local pelvic androgen levels and increased endometrial androgen receptor expression suggest that androgens are at least a co-factor in the development of endometrial cancer," Mertens said.

"If we can establish exactly what is going on...it may lead in the future to new treatments for the disease," she added.

According to the American Cancer Society, more than 36,000 new cases of cancer of the uterus, the majority of which occur in the endometrium, will be diagnosed this year.


"Reuters content is the intellectual property of Reuters Limited. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon."

 

 MedlinePlus is a resource for health information offered to the public by the US Government. The search box below will direct you to publicly available health information from the National Institutes of Health, the FDA and other government agencies.
Search MEDLINEplus:
 

MEDLINEplus en español

 
We subscribe to the HONcode principles of the Health On the Net Foundation


cancerpage.com 2000
- 2009 . Please send your feedback, comments and suggestions to our staff. Read our policies and terms of service . cancerpage.com is a service of Alere® .
© (2009) Inverness Medical. All Rights Reserved. Alere is a trademark of the Inverness Medical group of companies.